Page last updated: 2024-11-11

lasalocid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Lasalocid: Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers. It is used as a coccidiostat, especially in poultry. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

lasalocid : A polyether antibiotic used for prevention and treatment of coccidiosis in poultry. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5360807
CHEMBL ID145347
CHEBI ID92181
SCHEMBL ID259623
MeSH IDM0012243

Synonyms (93)

Synonym
x 537a
nsc-243048
ACON0_000529
(2r-(2alpha(2s*(3r*,4s*,5s*,7r*)3s*,5s*),5alpha,6beta))-6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-3-methylsalicylic acid
2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-, (-)-
benzoic acid, 6-(7(r)-(5(s)-ethyl-5-(5(r)-ethyltetrahydro-5-hydroxy-6(s)-methyl-2h-pyran-2(r)-yl)tetrahydro-3(s)-methyl-2(s)-furanyl)-4(s)-hydroxy-3(r),5(s)-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-
antibiotic x 537a
lasalocido [inn-spanish]
benzoic acid, 6-((3r,4s,5s,7r)-7-((2s,3s,5s)-5-ethyl-5-((2r,5r,6s)-5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-
antibiotic x 537
lasalocidum [inn-latin]
nsc 243048
lasalocide [inn-french]
ionophore x 537a
benzoic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-, (2r-(2alpha(2s*(3r*,4s*,5s*,7r*),3s*,5s*),5alpha,6beta))-
einecs 247-401-9
6-(7(r)-(5(s)-ethyl-5-(r)-ethyltetrahydro-5-hydroxy-6(s)-methyl-2h-pyran-2(r)-yl)tetrahydro-3(s)-methyl-2(s)-furyl)-4(s)-hydroxy-3(r),5(s)-dimethyl-6-oxononyl)-2,3-cresotic acid
x-537a
ro 2-2985
bovatec r
6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methylbenzoic acid (2r-(2alpha(2s*(3r*,4s*,5s*,7r*),3s*,5s*),5alpha,6beta))-
lasalocide a
6-(7(r)-(5(s)-ethyl-5-(5(r)-ethyltetrahydro-5-hydroxy-6(s)-methyl-2h-pyran-2(r)-yl)tetrahydro-3(s)-methyl-2(s)-furyl)-4(s)-hydroxy-3(r),5(s)-dimethyl-6-oxononyl)-2,3-cresotic acid
BSPBIO_000755
PRESTWICK3_000828
PRESTWICK2_000828
ACON1_002071
25999-31-9
lasalocid (usan/inn)
D04671
BPBIO1_000831
6-{7-[(5s)-5-((6s,5r)-5-ethyl-5-hydroxy-6-methylperhydro-2h-pyran-2-yl)-5-ethyl-3-methyloxolan-2-yl](4s,5s,3r,7r)-4-hydroxy-3,5-dimethyl-6-oxononyl}-2-hydroxy-3-methylbenzoic acid
6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyl-tetrahydropyran-2-yl]-3-methyl-tetrahydrofuran-2-yl]-4-hydroxy-3,5-dimethyl-6-oxo-nonyl]-2-hydroxy-3-methyl-benzoic acid
lasalocide
25999-20-6
NSC243046 ,
nsc243048
lasalocid
avatec
lasalocid a
MEGXM0_000441
PRESTWICK1_000828
PRESTWICK0_000828
SPBIO_002676
LMPK09000002
ro-22985
ro-2-2985
CHEMBL145347
6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid
lasalocido
lasalocid [usan:inn:ban]
lasalocidum
unii-w7v2zz2fwb
w7v2zz2fwb ,
lasalocid [mart.]
6-[7(r)-[5(s)-ethyl-5-(r)-ethyltetrahydro-5-hydroxy-6(s)-methyl-2h-pyran-2(r)-yl)tetrahydro-3(s)-methyl-2(s)-furyl]-4(s)-hydroxy-3(r),5(s)-dimethyl-6-oxononyl]-2,3-cresotic acid
lasalocid [inn]
lasalocid a [mi]
lasalocid [green book]
lasalocid [usan]
SCHEMBL259623
BBMULGJBVDDDNI-OWKLGTHSSA-N
CS-4627
DTXSID9048485 ,
HY-B1071
AKOS030526123
CHEBI:92181 ,
(1s,9s)-1,5:6,9-dianhydro-9-[(3r,5s,6s,7r)-9-(2-carboxy-3-hydroxy-4-methylphenyl)-6-hydroxy-5,7-dimethyl-4-oxononan-3-yl]-3,4,7,8-tetradeoxy-6-ethyl-2-c-ethyl-1,8-dimethyl-d-galacto-nonitol
6-[(3r,4s,5s,7r)-7-{(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]-3-methyltetrahydrofuran-2-yl}-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid
J-016218
ncgc00179860-02!6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid
Q3827314
DB11423
6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-benzoic acid
antibiotic x-537a
lasalocid-a
ionophore x-537a
NCGC00179860-02
A919355
F85230
lasalocid (x 537 a)
benzoic acid,6-[7-[5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, [2r-[2a[2s*(3r*,4s*,5s*,7r*),3s*,5s*],5a,6b]]-
d-galacto-nonitol, 1,5:6,9-dianhydro-9-c-[(1r,3s,4s,5r)-7-(2-carboxy-3-hydroxy-4-methylphenyl)-1-ethyl-4-hydroxy-3,5-dimethyl-2-oxoheptyl]-3,4,7,8-tetradeoxy-2,6-di-c-ethyl-8-methyl-1-c-methyl-, (1s,9 s)-
avatec, bovatec 150 fp, bovatec 68 type a medicated article, bovatec 91, bovatec liquid 20 (liquid type a article)
crystalyx iono-lyx
lasalocide (inn-french)
moorman's cattle minerals bt
purina sugar mag block 1440 bvt medicated mineral block
lasalocid (mart.)
lasalocido (inn-spanish)
6-((3r,4s,5s,7r)-7-((2s,3s,5s)-5-ethyl-5-((2r,5r,6s)-5-ethyl-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)-3-methyltetrahydrofuran-2-yl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methylbenzoic acid
dtxcid5028459
lasalocidum (inn-latin)

Research Excerpts

Overview

Lasalocid is a veterinary ionophore antibiotic used for prevention and treatment of coccidiosis in poultry. It contains a type of aromatic ring normally associated with fungal polyketides.

ExcerptReferenceRelevance
"Lasalocid is a veterinary ionophore antibiotic used for prevention and treatment of coccidiosis in poultry. "( Toxicity of the ionophore antibiotic lasalocid to soil-dwelling invertebrates: avoidance tests in comparison to classic sublethal tests.
Zidar, P; Žižek, S, 2013
)
2.11
"Lasalocid is an ionophore coccidiostatic agent frequently used in poultry. "( Cytoprotective effect of silybin against lasalocid-induced toxicity in HepG2 cells.
Cybulski, W; Radko, L; Rzeski, W, 2013
)
2.1
"Lasalocid is a veterinary ionophore antibiotic used for prevention and treatment of coccidiosis in poultry. "( Degradation and dissipation of the veterinary ionophore lasalocid in manure and soil.
Dobeic, M; Kobal, S; Pintarič, Š; Vidrih, M; Zidar, P; Žižek, S, 2015
)
2.11
"Lasalocid is a highly atypical polyether ionophoric antibiotic, firstly because it contains a type of aromatic ring normally associated with fungal polyketides, and secondly because the formation of its tetrahydropyran ring appears to contravene Baldwin's rules, which predict the kinetically preferred routes for cyclisation reactions in organic chemistry. "( Analysis of specific mutants in the lasalocid gene cluster: evidence for enzymatic catalysis of a disfavoured polyether ring closure.
Hong, H; Leadlay, PF; Smith, L; Spencer, JB, 2008
)
2.06
"Lasalocid is an ionophore antibiotic extensively used as a coccidiostat in poultry production. "( Lasalocid awareness and sampling in Scotland.
Roxburgh, JW; Wong, RY, 2010
)
3.25
"Lasalocid is a polyether ionophoric coccidiostat used for the prevention of coccidiosis in poultry at a prescribed concentration and during a certain time interval. "( Determination of lasalocid residues in the tissues of broiler chickens by liquid chromatography-tandem mass spectrometry.
Kožárová, I; Levkut, M; Mačanga, J; Tkáčiková, S, 2012
)
2.16
"Lasalocid acid is an important polyether ionophore veterinary drug. "( Fragmentation studies on lasalocid acid by accurate mass electrospray mass spectrometry.
Gates, PJ; Lopes, NP; Staunton, J; Wilkins, JP, 2002
)
2.06
"Bromolasalocid (Ro 20-0006) is a calcium ionophore with antihypertensive activity that does not belong to any known class of antihypertensive agents. "( Bromolasalocid (Ro 20-0006) antihypertensive ionophore.
Cohen, MR; Kovzelove, F; Osborne, MW; Wenger, JJ, 1983
)
1.29
"Lasalocid is a coccidiostat licensed for use in poultry, but not for use in egg-laying birds. "( The incidence and cause of lasalocid residues in eggs in Northern Ireland.
Blanchflower, WJ; Hughes, PJ; Kennedy, DG; McCaughey, WJ, 1996
)
2.03

Actions

Lasalocid resulted in lower acetate and butyrate with higher propionate and no change in total ruminal volatile fatty acids. Ground corn increased water intake.

ExcerptReferenceRelevance
"Lasalocid tended to increase water intake, and ground corn increased water intake."( Lasalocid and particle size of corn grain for dairy cows in early lactation. 2. Effect on ruminal measurements and feeding behavior.
Allen, MS; Erickson, PS; Knowlton, KF, 1996
)
2.46
"Lasalocid resulted in lower acetate and butyrate with higher propionate and no change in total ruminal volatile fatty acids."( Effect of lasalocid on growth and puberal development in Brahman bulls.
Neuendorff, DA; Peterson, LA; Randel, RD; Rutter, LM, 1985
)
1.39

Treatment

Lasalocid treatment increased milk volume milk protein and milk fat production by approximately 2%, without altering milk composition. No effect of serum swainsonine was observed.

ExcerptReferenceRelevance
"Lasalocid treatment increased milk volume milk protein and milk fat production by approximately 2%, without altering milk composition."( Production and health of pasture-fed dairy cattle following oral treatment with the ionophore lasalocid.
Anniss, FM; McDougall, S; Young, L, 2004
)
1.26
"Lasalocid-treated cells grew very slowly when they were resuspended in fresh medium."( Binding of radiolabeled monensin and lasalocid to ruminal microorganisms and feed.
Chow, JM; Russell, JB; Van Kessel, JA, 1994
)
1.28
"No lasalocid treatment (P = 0.7) or day (P = 0.1) effect of serum swainsonine was observed."( Effect of lonophore supplementation on selected serum constituents of sheep consuming locoweed.
Clayshulte, AK; Encinias, AM; Encinias, HB; Graham, JD; Strickland, JR; Taylor, JB; Whittet, KM, 2002
)
0.83
"The lasalocid treatment was identical except for the addition of 200 mg of lasalocid.animal-1.d-1."( Effect of lasalocid on the GnRH-induced LH and testosterone release during puberal development in the Brahman bull.
Neuendorff, DA; Peterson, LA; Randel, RD; Rutter, LM, 1991
)
1.16
"Lasalocid treatment at all levels prevented ABPE."( Reduction of 3-methylindole production and prevention of acute bovine pulmonary edema and emphysema with lasalocid.
Breeze, RG; Carlson, JR; Honeyfield, DC; Nocerini, MR, 1985
)
1.2
"Lasalocid treatment (L) was the control diet with the addition of 200 mg lasalocid X head-1 X d-1."( Effect of lasalocid on growth and puberal development in Brahman bulls.
Neuendorff, DA; Peterson, LA; Randel, RD; Rutter, LM, 1985
)
1.39

Toxicity

An investigation involving 640 turkeys demonstrated that the inclusion of lasalocid continuously from day-old to 16 weeks of age, at levels up to 375 ppm in the feed, produced no adverse effects. Based on the results of this study it appears that lasalOCid fed at the recommended rate of 125 ppm is safe in Chinese ring-necked pheasants.

ExcerptReferenceRelevance
"An investigation involving 640 turkeys demonstrated that the inclusion of lasalocid continuously from day-old to 16 weeks of age, at levels up to 375 ppm in the feed, produced no adverse effects; furthermore, the inclusion of 125 ppm lasalocid in the feed was compatible with the administration of 250 ppm tiamulin in the drinking water continuously for five days to turkeys over the same age range."( Safety of lasalocid in turkeys and its compatibility with tiamulin.
Comben, N; Fairley, C; Lodge, NJ; Roberts, NL, 1988
)
0.91
" We conclude that ITs are specifically toxic to established tumors."( Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
Jansen, FK; Runge, W; Vallera, DA; Weil-Hillman, G, 1985
)
0.27
" The LD50 of lasalocid for horses was estimated to be 21."( Toxic effects of lasalocid in horses.
Eisenbeis, HG; Givens, SV; Hanson, LJ, 1981
)
0.97
" Moreover, the drug was not toxic for cultures of rat astrocytes and C6 glioma cells."( Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel.
Bogin, E; Gurwitz, D; Halili, I; Haring, R; Levy, A; Safran, N; Shahar, A; Shainberg, A,
)
0.39
" Based on the results of this study it appears that lasalocid fed at the recommended rate of 125 ppm is safe in Chinese ring-necked pheasants."( Safety evaluation of lasalocid use in Chinese ring-necked pheasants (Phasianus colchicus).
Bender, H; Burrough, E; Dzikamunhenga, RS; Griffith, RW; Hostetter, J; Larson, W; Wilberts, B; Yaeger, M, 2013
)
0.96

Compound-Compound Interactions

ExcerptReferenceRelevance
" Four feeding trials were conducted to determine the performance of turkey poults when these compounds were used singly or in combination with 100 ppm of furazolidone."( Effect of including lasalocid or monensin singly or in combination with furazolidone on the growth and feed consumption of turkey poults.
Czarnecki, CM, 1990
)
0.6

Dosage Studied

Four rumen-fistulated cattle were used for each dosage level. Each animal receiving lasalocid, monensin, thiopeptin or no antibiotic. Four laboratories analyzed 35 dosed tissue samples and 82 fortified tissue samples.

ExcerptRelevanceReference
" Silylation was carried out directly without any extraction or prior cleanup, despite the complexity of the dosage forms."( GLC determination of lasalocid and its bromo analog as their silyl derivatives.
Manius, G; Viswanathan, V, 1977
)
0.58
" The development and frequency of these symptoms were dependent on the dosage of lasalocid and on the duration of the simultaneous administration."( Incompatibility between lasalocid and chloramphenicol in broiler chicks after a long-term simultaneous administration.
Broz, J; Frigg, M, 1987
)
0.81
" The cattle were given (orally) a single dosage of lasalocid (1, 10, 50, or 100 mg/kg of body weight) or monensin (25 mg/kg of body weight) or rice hulls."( Pathologic changes associated with experimental lasalocid and monensin toxicosis in cattle.
Galitzer, SJ; Kidd, JR; Kruckenberg, SM, 1986
)
0.78
" Rumen and blood samples were obtained before and at 6, 12, and 24 hours after each carbohydrate-antibiotic dosing to monitor acid-base status."( Effect of ionophore antibiotics on experimentally induced lactic acidosis in cattle.
Avery, TB; Galitzer, SJ; Harmon, DL; Nagaraja, TG, 1985
)
0.27
" Bromolasalocid produces a relatively flat systolic blood pressure dose-response effect in the spontaneously hypertensive rat."( Bromolasalocid (Ro 20-0006) antihypertensive ionophore.
Cohen, MR; Kovzelove, F; Osborne, MW; Wenger, JJ, 1983
)
1.26
" Four rumen-fistulated cattle were used for each dosage level and the design was a 4 x 4 Latin square with each animal receiving lasalocid, monensin, thiopeptin or no antibiotic."( Effect of lasalocid, monensin or thiopeptin on lactic acidosis in cattle.
Avery, TB; Bartley, EE; Dayton, AD; Nagaraja, TG; Roof, SK, 1982
)
0.87
" One of the 5 horses died after a dosage of 15 mg/kg, 1 of 3 horses died after 21 mg/kg, 1 of 3 horses died after 22 mg/kg, and 1 of 2 horses died after 26 mg/kg."( Toxic effects of lasalocid in horses.
Eisenbeis, HG; Givens, SV; Hanson, LJ, 1981
)
0.6
" Cumulative dose-response curves were constructed for KCl and histamine in the presence and absence of RO2-2985."( Differential inhibitory effects of the ionophore RO2-2985 (X537A) on contractile responses to potassium and histamine in coronary artery smooth muscle.
Berner, PF; Disalvo, J; Schwartz, A, 1980
)
0.26
" When the calves were about 2 weeks old they were each dosed orally with 550,000 sporulated Eimeria sp oocysts, mainly E zurneii and E bovis."( Control of coccidia in young calves using lasalocid.
Elliott, R; McMeniman, NP, 1995
)
0.56
" On d 10 after arrival, calves were orally dosed with 100,000 Eimeria oocysts."( Effects of lasalocid in milk replacer of calf starter on health and performance of calves challenged with Eimeria species.
Drewry, JJ; Ivey, SJ; Murray, LM; Quigley, JD, 1997
)
0.69
" Side effects such as the decline of the suckling reflex and intoxication symptoms in respect to present administration form and dosage were found only in one calf (9%)."( [Cryptosporidiosis in newborn calves in Ankara region: clinical, haematological findings and treatment with Lasalocid-NA].
Cizmeci, S; Karaer, Z; Sahal, M; Tanyel, B; Yasa Duru, S, 2005
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
coccidiostatAn agent useful in the treatment or prevention of coccidiosis in man or animals.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
ionophoreA compound which can carry specific ions through membranes of cells or organelles.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (8)

ClassDescription
monohydroxybenzoic acidAny hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.
beta-hydroxy ketoneA ketone containing a hydroxy group on the beta-carbon relative to the C=O group.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
oxolanesAny oxacycle having an oxolane (tetrahydrofuran) skeleton.
monocarboxylic acidAn oxoacid containing a single carboxy group.
oxanesAny organic heteromonocyclic compoundthat is oxane or its substituted derivatives.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
polyether antibiotic
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency17.78280.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID767346Selectivity index, ratio of IC50 for HLMEC cells to IC50 for human HT-29 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767350Selectivity index, ratio of IC50 for HLMEC cells to IC50 for mouse P388 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767355Cytotoxicity against human A549 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID51403The compound was tested for anti-coccidial activity in chicken against Eimeria praecox (DP-785) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID1660977Inhibition of Escherichia coli Stx1 in human HeLa cells assessed as stimulation of protein synthesis by measuring increase in [14C]-leucine incorporation incubated with cells for 3 hrs prior to Stx1 addition and further incubated for overnight and subsequ2020Journal of medicinal chemistry, 08-13, Volume: 63, Issue:15
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
AID51412Anticoccidial activity in chicken against E. tenella1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID51247The compound was tested for anti-coccidial activity in chicken against Eimeria maxima (DP-776) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID51233The compound was tested for anti-coccidial activity in chicken against Eimeria brunetti (FS-103) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID767343Selectivity index, ratio of IC50 for mouse BALB/3T3 cells to IC50 for human MCF7 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767347Selectivity index, ratio of IC50 for mouse BALB/3T3 cells to IC50 for human A549 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767352Cytotoxicity against HLMEC cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID51256The compound was tested for anti-coccidial activity in chicken against Eimeria mitis (LS-84) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID50775In vitro lethal dose of compound against Eimeria tenella in chicken kidney cell cultures1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Anticoccidial activity of crown polyethers.
AID25581Dissociation constant was determined1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Cluster significance analysis contrasted with three other quantitative structure-activity relationship methods.
AID767354Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767356Cytotoxicity against mouse P388 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767351Cytotoxicity against mouse BALB/3T3 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767353Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767344Selectivity index, ratio of IC50 for HLMEC cells to IC50 for human MCF7 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID767348Selectivity index, ratio of IC50 for HLMEC cells to IC50 for human A549 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID51092Anticoccidial activity in chicken against Eimeria acervulina.1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID23451Partition coefficient (logP)1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Cluster significance analysis contrasted with three other quantitative structure-activity relationship methods.
AID51094The compound was tested for anti-coccidial activity in chicken against Eimeria acervulina (DP-761) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID227520In vitro antibacterial activity was determined1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Cluster significance analysis contrasted with three other quantitative structure-activity relationship methods.
AID767349Selectivity index, ratio of IC50 for mouse BALB/3T3 cells to IC50 for mouse P388 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
AID51242The compound was tested for anti-coccidial activity in chicken against Eimeria hagani (DP-786) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID51414The compound was tested for anti-coccidial activity in chicken against Eimeria tenella (DP-761) measured at dose 100 (ppm in diet)1991Journal of medicinal chemistry, Sep, Volume: 34, Issue:9
Benzylated 1,2,3-triazoles as anticoccidiostats.
AID767345Selectivity index, ratio of IC50 for mouse BALB/3T3 cells to IC50 for human HT-29 cells2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (672)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990454 (67.56)18.7374
1990's109 (16.22)18.2507
2000's48 (7.14)29.6817
2010's46 (6.85)24.3611
2020's15 (2.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.77 (24.57)
Research Supply Index6.58 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index71.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (1.41%)5.53%
Reviews21 (2.97%)6.00%
Case Studies3 (0.42%)4.05%
Observational0 (0.00%)0.25%
Other673 (95.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]